194 related articles for article (PubMed ID: 14555387)
1. Epithelial membrane antigen (EMA) or MUC1 expression in monocytes and monoblasts.
Leong CF; Raudhawati O; Cheong SK; Sivagengei K; Noor Hamidah H
Pathology; 2003 Oct; 35(5):422-7. PubMed ID: 14555387
[TBL] [Abstract][Full Text] [Related]
2. Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay.
da Fonseca LM; Brunetti IL; Campa A; Catalani LH; Calado RT; Falcão RP
Hematol J; 2003; 4(1):26-30. PubMed ID: 12692517
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic application of monoclonal antibody KB90 (CD11c) in acute myeloid leukaemia.
Master PS; Richards SJ; Kendall J; Roberts BE; Scott CS
Blut; 1989 Sep; 59(3):221-5. PubMed ID: 2477088
[TBL] [Abstract][Full Text] [Related]
4. The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases.
Dunphy CH; Tang W
Arch Pathol Lab Med; 2007 May; 131(5):748-54. PubMed ID: 17488160
[TBL] [Abstract][Full Text] [Related]
5. Identification of acute myeloid leukemia in dogs using flow cytometry with myeloperoxidase, MAC387, and a canine neutrophil-specific antibody.
Villiers E; Baines S; Law AM; Mallows V
Vet Clin Pathol; 2006 Mar; 35(1):55-71. PubMed ID: 16511792
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of membrane CD11b, CD11c and CD14 expression in acute myeloid leukaemia: relationships with monocytic subtypes and the concept of relative antigen expression.
Scott CS; Richards SJ; Master PS; Kendall J; Limbert HJ; Roberts BE
Eur J Haematol; 1990 Jan; 44(1):24-9. PubMed ID: 1689668
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia.
Raife TJ; Lager DJ; Kemp JD; Dick FR
Am J Clin Pathol; 1994 Mar; 101(3):296-9. PubMed ID: 7510927
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation.
Churchill HRO; Fuda FS; Xu J; Deng M; Zhang CC; An Z; Zhang N; Chen P; Bergstrom C; Kansagra A; Collins R; John S; Koduru P; Chen W
Cytometry B Clin Cytom; 2021 Jul; 100(4):476-487. PubMed ID: 32918786
[TBL] [Abstract][Full Text] [Related]
9. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
10. The usefulness of CD64, other monocyte-associated antigens, and CD45 gating in the subclassification of acute myeloid leukemias with monocytic differentiation.
Krasinskas AM; Wasik MA; Kamoun M; Schretzenmair R; Moore J; Salhany KE
Am J Clin Pathol; 1998 Dec; 110(6):797-805. PubMed ID: 9844593
[TBL] [Abstract][Full Text] [Related]
11. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
12. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
[TBL] [Abstract][Full Text] [Related]
13. Identification of P-selectin glycoprotein ligand-1 as a useful marker in acute myeloid leukaemias.
Kappelmayer J; Kiss A; Karászi E; Veszprémi A; Jakó J; Kiss C
Br J Haematol; 2001 Dec; 115(4):903-9. PubMed ID: 11843824
[TBL] [Abstract][Full Text] [Related]
14. Role of blast cell immunophenotyping for the diagnosis and prognosis of acute myeloid leukemia.
Dubosc-Marchenay N; Lacombe F; Dumain P; Marit G; Montastruc M; Belloc F; Reiffers J
Hematol Oncol; 1992; 10(5):235-49. PubMed ID: 1493908
[TBL] [Abstract][Full Text] [Related]
15. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of CD19 as a marker of monocytic lineage in acute myelogenous leukemia.
Tisone JA; Bohman JE; Theil KS; Brandt JT
Am J Clin Pathol; 1997 Mar; 107(3):283-91. PubMed ID: 9052378
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies differentiating between monocytic and nonmonocytic variants of AML.
Linch DC; Allen C; Beverley PC; Bynoe AG; Scott CS; Hogg N
Blood; 1984 Mar; 63(3):566-73. PubMed ID: 6365201
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometry immunophenotypic characteristics of monocytic population in acute monocytic leukemia (AML-M5), acute myelomonocytic leukemia (AML-M4), and chronic myelomonocytic leukemia (CMML).
Gorczyca W
Methods Cell Biol; 2004; 75():665-77. PubMed ID: 15603447
[No Abstract] [Full Text] [Related]
19. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
[TBL] [Abstract][Full Text] [Related]
20. Expression of immune inhibitory receptor ILT3 in acute myeloid leukemia with monocytic differentiation.
Dobrowolska H; Gill KZ; Serban G; Ivan E; Li Q; Qiao P; Suciu-Foca N; Savage D; Alobeid B; Bhagat G; Colovai AI
Cytometry B Clin Cytom; 2013; 84(1):21-9. PubMed ID: 23027709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
